Literature DB >> 9521705

Forskolin-induced dephosphorylation of the androgen receptor impairs ligand binding.

L J Blok1, P E de Ruiter, A O Brinkmann.   

Abstract

When androgen receptor containing cells are cultured in the presence of the PKA stimulator forskolin, a rapid dephosphorylation of the androgen receptor occurs resulting in a decrease in the amount of 112 kDa androgen receptor isoform and an increase in 110 kDa androgen receptor isoform on SDS-PAGE. To establish which amino acid residues in the androgen receptor were phosphorylated in control and forskolin-treated cells, trypsin-digested androgen receptors were subjected to RP-HPLC analysis and subsequently to Edman degradation. It was observed that serine residues 506, 641, and 653 were potentially phosphorylated in control cells, while after forskolin treatment strong evidence was obtained that phosphorylation of serines 641 and 653 was significantly reduced. When the dephosphorylated androgen receptor was analyzed for its transcription activation capacity, it was observed that androgen-induced transcriptional regulation of two endogenous genes (PSA) and beta 1-subunit of Na,K-ATPase), in cells cultured in the presence of forskolin, was inhibited as compared to the control situation. The observation that the dephosphorylated androgen receptor was transcriptionally less active was further strengthened by the finding that the dephosphorylated androgen receptor was markedly impaired in ligand binding (Bmax was found to be reduced by approximately 40%). The current investigations show for the first time a clear function for the rapid phosphorylation which occurs directly after synthesis of the androgen receptor, namely, effective ligand binding.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9521705     DOI: 10.1021/bi9724422

Source DB:  PubMed          Journal:  Biochemistry        ISSN: 0006-2960            Impact factor:   3.162


  14 in total

Review 1.  Molecules targeting the androgen receptor (AR) signaling axis beyond the AR-Ligand binding domain.

Authors:  N G R Dayan Elshan; Matthew B Rettig; Michael E Jung
Journal:  Med Res Rev       Date:  2018-11-22       Impact factor: 12.944

2.  Kinase modulation of androgen receptor signaling: implications for prostate cancer.

Authors:  Kalpit Shah; Neil A Bradbury
Journal:  Cancer Cell Microenviron       Date:  2015-11-19

3.  Synthesis and phosphorylation of androgen receptor of the mouse brain cortex and their regulation by sex steroids during aging.

Authors:  M K Thakur; A Asaithambi; S Mukherjee
Journal:  Mol Cell Biochem       Date:  2000-01       Impact factor: 3.396

4.  Activation of androgen receptor function by a novel nuclear protein kinase.

Authors:  A M Moilanen; U Karvonen; H Poukka; O A Jänne; J J Palvimo
Journal:  Mol Biol Cell       Date:  1998-09       Impact factor: 4.138

5.  Identification of androgen receptor phosphorylation in the primate ovary in vivo.

Authors:  Iain J McEwan; Dagmara McGuinness; Colin W Hay; Robert P Millar; Philippa T K Saunders; Hamish M Fraser
Journal:  Reproduction       Date:  2010-04-20       Impact factor: 3.906

6.  Behavioral stress accelerates prostate cancer development in mice.

Authors:  Sazzad Hassan; Yelena Karpova; Daniele Baiz; Dana Yancey; Ashok Pullikuth; Anabel Flores; Thomas Register; J Mark Cline; Ralph D'Agostino; Nika Danial; Sandeep Robert Datta; George Kulik
Journal:  J Clin Invest       Date:  2013-01-25       Impact factor: 14.808

7.  Regulation of expression of Na+,K+-ATPase in androgen-dependent and androgen-independent prostate cancer.

Authors:  L J Blok; G T Chang; M Steenbeek-Slotboom; W M van Weerden; H G Swarts; J J De Pont; G J van Steenbrugge; A O Brinkmann
Journal:  Br J Cancer       Date:  1999-09       Impact factor: 7.640

8.  Proline-Directed Androgen Receptor Phosphorylation.

Authors:  Yanfei Gao; Shaoyong Chen
Journal:  J Mol Genet Med       Date:  2013-10

9.  Androgen receptor phosphorylation at serine 515 by Cdk1 predicts biochemical relapse in prostate cancer patients.

Authors:  J M Willder; S J Heng; P McCall; C E Adams; C Tannahill; G Fyffe; M Seywright; P G Horgan; H Y Leung; M A Underwood; J Edwards
Journal:  Br J Cancer       Date:  2012-12-04       Impact factor: 7.640

10.  Epithelial Na, K-ATPase expression is down-regulated in canine prostate cancer; a possible consequence of metabolic transformation in the process of prostate malignancy.

Authors:  Ali Mobasheri; Richard Fox; Iain Evans; Fay Cullingham; Pablo Martín-Vasallo; Christopher S Foster
Journal:  Cancer Cell Int       Date:  2003-06-13       Impact factor: 5.722

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.